Moonsik Kim
Overview
Explore the profile of Moonsik Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Choi J, Kwon H, Kim M
In Vivo
. 2024 Oct;
38(6):2904-2911.
PMID: 39477398
Background/aim: Endoscopic submucosal dissection (ESD) effectively treats selected early gastric cancers (EGCs). However, the association of microsatellite instability (MSI), Epstein-Barr virus (EBV), p53, and β-catenin status with clinicopathologic parameters in...
2.
Kim M, Kang B, Park J, Baek J, Kim J
Pathol Res Pract
. 2024 Oct;
263:155628.
PMID: 39368365
Background: Poorly cohesive carcinoma (PCC) is a distinct subtype of gastric cancer with limited therapeutic options. This study investigated claudin (CLDN) 18.2 expression status in PCCs using a 43-13 A...
3.
Park J, Seo A, Kim M
In Vivo
. 2024 Jun;
38(4):1865-1874.
PMID: 38936896
Background/aim: Gastric cancer and its precancerous lesions represent a significant public health concern. A subset of gastric cancers exhibits mutations in the TP53 gene, often accompanying distinctive morphologic alterations. This...
4.
Ahn S, Kwak Y, Kwon G, Kim K, Kim M, Kim H, et al.
J Pathol Transl Med
. 2024 Apr;
58(3):103-116.
PMID: 38653580
Nivolumab plus chemotherapy in the first-line setting has demonstrated clinical efficacy in patients with human epidermal growth factor receptor 2-negative advanced or metastatic gastric cancer, and is currently indicated as...
5.
Park J, Cho H, Seo J, Park K, Kwon Y, Bae H, et al.
Sci Rep
. 2023 Nov;
13(1):19487.
PMID: 37945587
Epstein-Barr virus (EBV)-associated gastric cancer (EBVaGC) is a distinct molecular subtype of gastric cancer. This study aims to investigate genomic and clinicopathological characteristics of EBVaGC according to the histological pattern....
6.
Kim M, Kim J, Seo A, Jeong J, Park N, Chong G, et al.
Pathol Res Pract
. 2023 Oct;
251:154879.
PMID: 37862920
Background: Phosphatase and tensin homolog (PTEN) is one of the most frequently mutated tumor suppressor genes in malignant tumors. Oncogenic PTEN mutations have diagnostic, prognostic, and therapeutic implications. Similar to...
7.
Kim M, Jeong J, Seo A
Diagnostics (Basel)
. 2023 Sep;
13(17).
PMID: 37685320
Despite advances in diagnostic imaging, surgical techniques, and systemic therapy, gastric cancer (GC) is the third leading cause of cancer-related death worldwide. Unfortunately, molecular heterogeneity and, consequently, acquired resistance in...
8.
Park K, Seo A, Kim M
Diagn Pathol
. 2023 Jul;
18(1):81.
PMID: 37434198
Background: Epstein-Barr virus (EBV)-associated gastric cancer exhibits distinct clinicopathologic characteristics, showing a good response to immune checkpoint inhibitors and a favorable prognosis. However, gastric cancer comprising distinct EBV-positive and -negative...
9.
Kim J, Ko S, Kim M, Park N, Han H, Cho J, et al.
Medicina (Kaunas)
. 2023 Mar;
59(3).
PMID: 36984536
objectives: Telomerase reverse transcriptase () promoter mutation, found in a subset of patients with thyroid cancer, is strongly associated with aggressive biologic behavior. Predicting promoter mutation is thus necessary for...
10.
Kim M, Lee C, Hong J, Kim J, Jeong J, Park N, et al.
Cancer Res Treat
. 2022 Dec;
55(2):429-441.
PMID: 36470260
Purpose: Targeted next-generation sequencing (NGS) is widely used for simultaneously detecting clinically informative genetic alterations in a single assay. Its application in clinical settings requires the validation of NGS gene...